ArticleAdvances in respiratory medicine2025

Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy.

Mandeep Chouhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.